Eli Lilly and Company (LLY)
Free fundamentals built from Eli Lilly and Company's SEC filings. The narrative and events research is readable on this site as pages, and every file is published in a machine format too: financial statements as JSON, narrative and events as Markdown. No signup, no API key. Files are replaced in place each quarter, so these URLs are permanent. Agents: fetch index.json for this directory as a machine-readable manifest, /tickers.json for every covered company, or /llms.txt for site-wide conventions.
Company details
| Name | ELI LILLY & Co |
|---|---|
| Ticker | LLY |
| CIK | 0000059478 |
| Exchange | NYSE |
| State | Indiana |
| Incorporation | Indiana |
| SIC | 2834 |
| Office | Life Sciences |
| Industry | Pharmaceutical Preparations |
| Latest period covered | Q1 FY2026, ended 2026-03-31, 10-Q, accession 0000059478-26-000045 |
| Fiscal year end | 12/31 (MM/DD) |
| Next expected filing | 10-Q around 2026-08-06 (predicted) |
Data files
- financials.jsonJSON Annual financial statements plus the latest quarter: income statement, balance sheet, cash flow. Actual dollars, actual shares. Sourcing notes and uncertainties included.
- NarrativePage Qualitative synthesis of the latest 10-K + 10-Q: business, risk factors (quarter-over-quarter changes flagged), MD&A, legal proceedings, subsequent events. narrative.mdMarkdown
- EventsPage Digest of material 8-K filings: earnings headlines, management changes, capital-return and financing actions, governance. SEC accession numbers cited throughout. events.mdMarkdown
- index.jsonJSON This directory listing as a machine-readable manifest.
Data extracted from SEC filings (accession numbers cited in each file). Free to cite with attribution: Ticker Scout (tickerscout.ai). Not investment advice, see the Disclaimer.